JP2007506664A5 - - Google Patents

Download PDF

Info

Publication number
JP2007506664A5
JP2007506664A5 JP2006515980A JP2006515980A JP2007506664A5 JP 2007506664 A5 JP2007506664 A5 JP 2007506664A5 JP 2006515980 A JP2006515980 A JP 2006515980A JP 2006515980 A JP2006515980 A JP 2006515980A JP 2007506664 A5 JP2007506664 A5 JP 2007506664A5
Authority
JP
Japan
Prior art keywords
formula
compound
alkyl
optionally
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006515980A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007506664A (ja
Filing date
Publication date
Priority claimed from GBGB0314488.8A external-priority patent/GB0314488D0/en
Application filed filed Critical
Publication of JP2007506664A publication Critical patent/JP2007506664A/ja
Publication of JP2007506664A5 publication Critical patent/JP2007506664A5/ja
Pending legal-status Critical Current

Links

JP2006515980A 2003-06-20 2004-06-16 マトリックスメタロプロテイナーゼの阻害剤 Pending JP2007506664A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0314488.8A GB0314488D0 (en) 2003-06-20 2003-06-20 Therapeutically useful compounds
PCT/EP2004/006553 WO2004113279A1 (en) 2003-06-20 2004-06-16 Inhibitors of matrix metalloproteinase

Publications (2)

Publication Number Publication Date
JP2007506664A JP2007506664A (ja) 2007-03-22
JP2007506664A5 true JP2007506664A5 (enExample) 2007-07-26

Family

ID=27637076

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006515980A Pending JP2007506664A (ja) 2003-06-20 2004-06-16 マトリックスメタロプロテイナーゼの阻害剤

Country Status (5)

Country Link
US (2) US7375248B2 (enExample)
EP (1) EP1636174A1 (enExample)
JP (1) JP2007506664A (enExample)
GB (1) GB0314488D0 (enExample)
WO (1) WO2004113279A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0321538D0 (en) * 2003-09-13 2003-10-15 Glaxo Group Ltd Therapeutically useful compounds
EA013539B1 (ru) 2005-02-22 2010-06-30 Рэнбакси Лабораториз Лимитед Производные 5-фенилпентановой кислоты в качестве ингибиторов матричной металлопротеиназы для лечения астмы и других заболеваний
JO2868B1 (en) 2006-08-22 2015-03-15 رانبكسي لابوراتوريز ليمتد Inhibitors of metabolic protein protein enzyme
WO2010056527A2 (en) * 2008-10-30 2010-05-20 Gilead Palo Alto, Inc. Fused heterocyclic compounds as ion channel modulators
US8987315B2 (en) 2009-12-31 2015-03-24 Innocrin Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
CN103209960A (zh) 2010-07-26 2013-07-17 百时美施贵宝公司 用作cyp17抑制剂的磺酰胺化合物
CN103119030A (zh) 2010-07-30 2013-05-22 兰贝克赛实验室有限公司 基质金属蛋白酶抑制剂
US20140148459A1 (en) 2010-09-24 2014-05-29 Ranbaxy Laboratories Limited Matrix metalloproteinase inhibitors
JP2013538821A (ja) 2010-09-24 2013-10-17 ランバクシー ラボラトリーズ リミテッド マトリックスメタロプロテイナーゼ阻害剤
EP2926808A1 (en) 2012-11-28 2015-10-07 Administración General De La Communidad Autónoma De Euskadi Use of metalloprotease inhibitors for the treatment of polycystic liver diseases

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139626A (en) 1975-05-29 1976-12-02 Sumitomo Chem Co Ltd A herbicide and a process for its preparation
AT368358B (de) * 1977-12-24 1982-10-11 Fisons Ltd Schaedlingsbekaempfungs- und pflanzenwachstumsregulierungsmittel
US5852192A (en) * 1992-03-11 1998-12-22 Dr. Karl Thomae Gmbh Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
US5710171A (en) * 1995-05-24 1998-01-20 Merck & Co., Inc. Bisphenyl inhibitors of farnesyl-protein transferase
EP0795550B1 (en) * 1996-03-11 2002-06-05 Sankyo Company Limited Aniline derivatives having herbicidal activity their preparation and their use
CZ294063B6 (cs) * 1996-05-17 2004-09-15 Warner-Lambert Company Bifenylsulfonamid, jeho použití a farmaceutický prostředek s jeho obsahem
WO1998009940A1 (en) * 1996-09-04 1998-03-12 Warner-Lambert Company Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
GB9801690D0 (en) * 1998-01-27 1998-03-25 Pfizer Ltd Therapeutic agents
JPH11236369A (ja) * 1998-02-23 1999-08-31 Kotobuki Seiyaku Kk スルホンアミド誘導体及びその製造法並びにこれを含有する医薬組成物
HK1047274A1 (zh) * 1999-07-01 2003-02-14 大正制药株式会社 氨基苯甲酸衍生物
US6451832B2 (en) * 1999-12-23 2002-09-17 Boehringer Ingelheim Pharma Kg Benzimidazoles with antithrombotic activity
AU4882101A (en) * 2000-04-28 2001-11-12 Shionogi & Co., Ltd. Mmp-12 inhibitors
JP2002205986A (ja) * 2000-11-08 2002-07-23 Takeda Chem Ind Ltd ピリミジン誘導体およびそれを含有する除草剤
JP2002193800A (ja) 2000-12-22 2002-07-10 Taisho Pharmaceut Co Ltd Vegf受容体拮抗剤
JP2005504727A (ja) * 2001-04-13 2005-02-17 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 抗炎症薬として有用なウレア化合物
GB0124928D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
WO2003035610A1 (en) * 2001-10-26 2003-05-01 Shionogi & Co., Ltd. Sulfonamide derivative having mmp inhibitory activity

Similar Documents

Publication Publication Date Title
JP2006526590A5 (enExample)
JP2006507265A5 (enExample)
JP2009502743A5 (enExample)
JP2006526031A5 (enExample)
JP2007523139A5 (enExample)
JP2007510619A5 (enExample)
JP2004536811A5 (enExample)
JP2009538336A5 (enExample)
JP2006525365A5 (enExample)
JP2005530811A5 (enExample)
JP2010520214A5 (enExample)
JP2006504738A5 (enExample)
JP2007502817A5 (enExample)
JP2005516898A5 (enExample)
JP2005517008A5 (enExample)
JP2004525178A5 (enExample)
JP2004523478A5 (enExample)
EP1712548A3 (en) 5-amino-4-hydroxy-7-(pyridinylmethyl)-alkanamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
JP2004510750A5 (enExample)
JP2005502636A5 (enExample)
JP2010510263A5 (enExample)
JP2008520662A5 (enExample)
JP2011508779A5 (enExample)
JP2004538278A5 (enExample)
JP2006505567A5 (enExample)